ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
AB Corporate Bond ETF

AB Corporate Bond ETF (EYEG)

35.735
0.01
(0.03%)
Cerrado 23 Noviembre 3:00PM
35.735
0.00
(0.00%)
Fuera de horario: 3:03PM

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
35.735
Postura de Compra
26.80
Postura de Venta
44.66
Volume Operado de la Acción
46
0.00 Rango del Día 0.00
34.52 Rango de 52 semanas 37.24
Capitalización de Mercado [m]
Precio Anterior
35.725
Precio de Apertura
-
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
567
Acciones en circulación
7,689,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-1.99
Beneficio por acción (BPA)
-1.7
turnover
-
Beneficio neto
-13.05M

Acerca de AB Corporate Bond ETF

The Fund is an actively-managed exchange-traded fund (ETF). The Fund pursues its objective by investing, under normal circumstances, at least 80% of its net assets, including any borrowings for investment purposes, in investment grade fixed-income securities of corporate issuers. Corporate issuers m... The Fund is an actively-managed exchange-traded fund (ETF). The Fund pursues its objective by investing, under normal circumstances, at least 80% of its net assets, including any borrowings for investment purposes, in investment grade fixed-income securities of corporate issuers. Corporate issuers may include corporate or other business entities in which a sovereign or governmental agency or entity may have, indirectly or directly, an interest, including a majority or greater ownership interest. The Funds investment objective is to maximize total return through current income and longterm capital appreciation. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
-
AB Corporate Bond ETF is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker EYEG. The last closing price for AB Corporate Bond ETF was US$35.73. Over the last year, AB Corporate Bond ETF shares have traded in a share price range of US$ 34.52 to US$ 37.24.

AB Corporate Bond ETF currently has 7,689,000 shares in issue. The market capitalisation of AB Corporate Bond ETF is US$274.69 million. AB Corporate Bond ETF has a price to earnings ratio (PE ratio) of -1.99.

EYEG Últimas noticias

EyeGate Pharmaceuticals to Present at BIO CEO & Investor Conference in New York City

WALTHAM, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”) today announced that the Company will attend and present at the 21st...

EyeGate Pharmaceuticals Announces Meeting Date with FDA

WALTHAM, Mass., Jan. 16, 2019 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”) today confirmed that it is scheduled to meet with the U.S. Food and...

EyeGate Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update

WALTHAM, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”) today announced financial results for the three-month period ended...

EyeGate Pharma Announces Positive Results in Second PRK Study

Data confirms results from earlier study WALTHAM, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) today announced top-line data from its study evaluating...

EyeGate Pharmaceuticals Signs Technology Transfer and License Agreement with SentrX Animal Care

WALTHAM, Mass., Oct. 02, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

EyeGate Pharmaceuticals Granted Additional 180 Days to Comply With Nasdaq Listing Rules

WALTHAM, Mass., Sept. 25, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

EyeGate Pharmaceuticals Completes Enrollment in Both PRK and PE Pilot Studies

WALTHAM, Mass., Sept. 24, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

EyeGate Announces Randomization of First Patients in Study for Punctate Epitheliopathies

WALTHAM, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

EyeGate Announces Top-Line Results for Phase 3 Trial of EGP-437 in Anterior Uveitis

WALTHAM, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.1150.32285233015235.6235.81535.62235.6984SP
4-0.335-0.92874965345236.0736.1135.69735.91877451SP
12-0.935-2.5497682028936.6737.2435.656736.72061394SP
260.41431.1729665606935.320737.2434.9158636.40075307SP
520.5351.5198863636435.237.2434.5251735.8830834SP
1560.5351.5198863636435.237.2434.5251735.8830834SP
2600.5351.5198863636435.237.2434.5251735.8830834SP

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
PDYNPalladyne AI Corporation
US$ 4.59
(129.50%)
83.07M
QMCOQuantum Corporation
US$ 9.11
(126.62%)
39.48M
NANano Labs Ltd
US$ 8.26
(89.02%)
2.03M
XCURExicure Inc
US$ 18.60
(71.27%)
4.59M
SKKSKK Holdings Limited
US$ 1.75
(59.09%)
107.47M
AMIXAutonomix Medical Inc
US$ 6.21
(-54.07%)
946.09k
CETXCemtrex Inc
US$ 0.1146
(-41.74%)
24.39M
MSWMing Shing Group Holdings Ltd
 5.90
(-35.52%)
417.08k
RMSGReal Messenger Corporation
US$ 3.09
(-26.25%)
313.51k
ENSCEnsysce Biosciences Inc
US$ 0.4414
(-25.49%)
4M
ELABElevai Labs Inc
US$ 0.0201
(-0.50%)
425.38M
NVDANVIDIA Corporation
US$ 141.95
(-3.22%)
236.51M
SMCISuper Micro Computer Inc
US$ 33.15
(11.62%)
159.61M
VRPXVirpax Pharmaceuticals Inc
US$ 0.5501
(-6.72%)
159.39M
SOUNSoundHound AI Inc
US$ 8.24
(18.05%)
107.91M
123tom 123tom 3 minutos hace
Great post. I'd use the same trade process you described. Do you use any leverage in your trading?
nelson1234 nelson1234 3 minutos hace
that's basically how I feel. All else equal, either Massey or India goes to third B.
BigBadWolf BigBadWolf 4 minutos hace
Simply compare https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175428528&txt2find=Please
Your $ base it’s use on your DD
Then watch for what follows as ControllabilityIam
The good, the bad & the ugly

Also above quotes are history verified….must b
AFFU
mrfence mrfence 4 minutos hace
Thumbs 👍 👨
FNMA
xmancometh7 xmancometh7 4 minutos hace
PLEASE DONT RESPOND TO THIS POSTER...HES FULL OF IT...IF IT GOES DOWN HE'LL SAY HE SOLD HIGH AND MADE TONS...IF IT KEEP GOING UP HE'LL SAY HE DIDNT SELL AND MADE TONS...ALL BOARDS HAVE THESE "PERFECT" TRADERS...THEY'RE CLULESS LOL
RDAR
dinogreeves dinogreeves 4 minutos hace
Meta this week said to be investing huge in AI data centers and they are also huge partners with Super Micro. There is only one direction with SMCI and that is way up North.
SMCI
facts_matter14 facts_matter14 5 minutos hace
BEST SELLERS RANK (BSR) shows POSVOS sales are happening at a rate of under 250 per year. (Even though the Q3 showed less than 30 were sold in the quarter)

And I’m going to post about it 24/7/365.

Every holiday, every day that ends in “Y”, multiple times per day, all th
SRMX
nelson1234 nelson1234 6 minutos hace
thanks a bunch otc.. best.
BIG BALLER BIG BALLER 7 minutos hace
$XTZ just look at the volume under $2 ~ accumulation in progress :-D woot!

[yt]gNNPxosY-jg[/yt]
XTZ
nelson1234 nelson1234 7 minutos hace
thanks novice... best....
Twilson Twilson 8 minutos hace
Think IWM making a surge to the 243 area?
IWM
dinogreeves dinogreeves 9 minutos hace
Thank you LJ.

https://stockanalysis.com/stocks/smci/employees/#
SMCI
123tom 123tom 9 minutos hace
I'm tempted to sit back and let it run... but that's what I did last time it spiked past 10.... and then it tumbled to 7.20. And I missed a good trade.
If we get some good news for real momentum and volume, then a new support level at 8 can climb to 11,12 and higher, creating a new chart pic
AVXL
Gmenfan Gmenfan 10 minutos hace
See the list of Trump Cabinet picks and more White House appointments so far

https://www.cbsnews.com/news/who-might-be-in-donald-trump-cabinet/
Disquisition Disquisition 11 minutos hace
Cry even HARDER!!!!

BAW HAW HAW HAW HAW!!!! I LOVE seeing you seethe and rant and rave like an out-of-control leftist maniac !!!!!

Would have been much easier just to listen to us when we said TRUMP would win, eh?

Nah...keep on CRYING and WHINING and hide
Gmenfan Gmenfan 11 minutos hace
See the list of Trump Cabinet picks and more White House appointments so far

https://www.cbsnews.com/news/who-might-be-in-donald-trump-cabinet/
blackhawks blackhawks 11 minutos hace
The origin of the virus excuses exactly NONE of Trump's misjudgments, criminal negligence and junk science driven stupidity that were behind his asinine decision to publicly downplay Covid, and riff about absurd non-treatments, while knowing better.

Perhaps you can find information to
Make It Jake Make It Jake 12 minutos hace
Current AIM-CASH S&P 500 weekly value : 55.3%

This is an increase from last week’s value. The tables show a look-back over historical data from 1947 to 2024 summarizing the 60 weeks in which the AIM-CASH value was at or nearest to this level.

(Links to Clive’s origin
capgain capgain 12 minutos hace
Oliver Anthony - Country Roads

https://www.youtube.com/watch?v=Ut4c-GTABwc
fuagf fuagf 13 minutos hace
No reply from admin. doesn't deter from the annoyance factor.

If i've missed something on that score, apology to admin.
Eagle1 Eagle1 14 minutos hace
https://x.com/VsraTweets/status/1860310573243580761
GDVM
Gmenfan Gmenfan 15 minutos hace
Jurassic revolt: Democrats' 70-year-olds rebel against Democrats' 80-year-olds over House committee seats -Axios

By Monica Showalter

It's not easy being a House Democrat.

The party's perky, youthful 60- and 70-year olds are in open revolt against the part
Gmenfan Gmenfan 16 minutos hace
Jurassic revolt: Democrats' 70-year-olds rebel against Democrats' 80-year-olds over House committee seats -Axios

By Monica Showalter

It's not easy being a House Democrat.

The party's perky, youthful 60- and 70-year olds are in open revolt against the part
HoldHigh HoldHigh 16 minutos hace
IMO it wouldn’t and this is why. Texas’s Compassionate Use Program (CUP) allows certain physicians to prescribe low tetrahydrocannabinols (THC) cannabis for medical purposes.

Low-THC comes from the plant Cannabis Sativa L. All parts of the plant and any resulting compounds, salts,
TCNNF
SSKILLZ1 SSKILLZ1 17 minutos hace
Pick 4 Contest #20 Standings (Week 27)

Congrats to our current leader NOVICETRADER up 146.99% so far in the contest. There are 23/34 portfolio up in the contest or 67.65%. So without any further ado the info. is below.
[pre]
Alias % Gain/Loss

Su Consulta Reciente

Delayed Upgrade Clock